CFAP20DC-AS1

Across TCGA pan-cancer cohorts, CFAP20DC-AS1 RNA differs between tumor and matched normal tissue in 8 of 18 cancer types tested, making tumor–normal expression one of CFAP20DC-AS1’s most consistent transcriptional readouts.

The strongest signal is observed in kidney renal clear cell carcinoma (KIRC), where CFAP20DC-AS1 RNA is more highly expressed in tumor relative to normal tissue. In most cancer types CFAP20DC-AS1 is over-expressed in tumor, although a few such as COAD show the opposite, repressed pattern.

KIRC, LIHC, and KIRP are the cancer types where CFAP20DC-AS1 tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in CFAP20DC-AS1 RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
KIRC	Male	All	+0.062	<.001	10	view →
LIHC	Male	All	+0.153	<.001	6	view →
KIRP	All	All	+0.022	.003	6	view →
LUSC	All	All	+0.016	.001	5	view →
BRCA	All	All	+0.071	.042	2	view →
COAD	Male	II,III,IV	−0.047	.024	2	view →
CHOL	All	All	+0.094	.048	1	view →
HNSC	All	All	+0.007	.046	1	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 8 strongest of 8 lineages.

CFAP20DC-AS1–KIRC

Open the KIRC breakdown →